135 related articles for article (PubMed ID: 38746988)
21. Rett-like Phenotypes in
Gonzalez JN; Goldman S; Carter MT; Bain JM
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372334
[TBL] [Abstract][Full Text] [Related]
22. A Cas9-fusion proximity-based approach generates an Irak1-Mecp2 tandem duplication mouse model for the study of MeCP2 duplication syndrome.
Maino E; Scott O; Rizvi SZ; Chan WS; Visuvanathan S; Zablah YB; Li H; Sengar AS; Salter MW; Jia Z; Rossant J; Cohn RD; Gu B; Ivakine EA
Dis Model Mech; 2024 Jun; ():. PubMed ID: 38881329
[TBL] [Abstract][Full Text] [Related]
23. MeCP2 mutations in children with and without the phenotype of Rett syndrome.
Hoffbuhr K; Devaney JM; LaFleur B; Sirianni N; Scacheri C; Giron J; Schuette J; Innis J; Marino M; Philippart M; Narayanan V; Umansky R; Kronn D; Hoffman EP; Naidu S
Neurology; 2001 Jun; 56(11):1486-95. PubMed ID: 11402105
[TBL] [Abstract][Full Text] [Related]
24. A case report of Chinese brothers with inherited MECP2-containing duplication: autism and intellectual disability, but not seizures or respiratory infections.
Xu X; Xu Q; Zhang Y; Zhang X; Cheng T; Wu B; Ding Y; Lu P; Zheng J; Zhang M; Qiu Z; Yu X
BMC Med Genet; 2012 Aug; 13():75. PubMed ID: 22909152
[TBL] [Abstract][Full Text] [Related]
25. Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors.
Varderidou-Minasian S; Hinz L; Hagemans D; Posthuma D; Altelaar M; Heine VM
Mol Autism; 2020 May; 11(1):38. PubMed ID: 32460858
[TBL] [Abstract][Full Text] [Related]
26. MECP2-related disorders while gene-based therapies are on the horizon.
Allison K; Maletic-Savatic M; Pehlivan D
Front Genet; 2024; 15():1332469. PubMed ID: 38410154
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of Spanish patients with MECP2 duplication syndrome.
Pascual-Alonso A; Blasco L; Vidal S; Gean E; Rubio P; O'Callaghan M; Martínez-Monseny AF; Castells AA; Xiol C; Català V; Brandi N; Pacheco P; Ros C; Del Campo M; Guillén E; Ibañez S; Sánchez MJ; Lapunzina P; Nevado J; Santos F; Lloveras E; Ortigoza-Escobar JD; Tejada MI; Maortua H; Martínez F; Orellana C; Roselló M; Mesas MA; Obón M; Plaja A; Fernández-Ramos JA; Tizzano E; Marín R; Peña-Segura JL; Alcántara S; Armstrong J
Clin Genet; 2020 Apr; 97(4):610-620. PubMed ID: 32043567
[TBL] [Abstract][Full Text] [Related]
28. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome.
Ramocki MB; Peters SU; Tavyev YJ; Zhang F; Carvalho CM; Schaaf CP; Richman R; Fang P; Glaze DG; Lupski JR; Zoghbi HY
Ann Neurol; 2009 Dec; 66(6):771-82. PubMed ID: 20035514
[TBL] [Abstract][Full Text] [Related]
29. Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.
Vermudez SAD; Buch A; Weiss K; Gogliotti RG; Niswender CM
Neuropharmacology; 2022 May; 209():109022. PubMed ID: 35248529
[TBL] [Abstract][Full Text] [Related]
30. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
Heckman LD; Chahrour MH; Zoghbi HY
Elife; 2014 Jun; 3():. PubMed ID: 24970834
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
32. Genetic analysis of a pedigree with MECP2 duplication syndrome in China.
Zeng L; Zhu H; Wang J; Wang Q; Pang Y; Luo Z; Chen A; Qin S; Zhu S
BMC Med Genomics; 2024 Feb; 17(1):54. PubMed ID: 38373942
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain.
Carli S; Chaabane L; De Rocco G; Albizzati E; Sormonta I; Calligaro S; Bonizzi P; Frasca A; Landsberger N
Neurobiol Dis; 2023 May; 180():106083. PubMed ID: 36931532
[TBL] [Abstract][Full Text] [Related]
34. Relation between circulating levels of GH, IGF-1, ghrelin and somatic growth in Rett syndrome.
Hara M; Nishi Y; Yamashita Y; Hirata R; Takahashi S; Nagamitsu S; Hosoda H; Kangawa K; Kojima M; Matsuishi T
Brain Dev; 2014 Oct; 36(9):794-800. PubMed ID: 24377437
[TBL] [Abstract][Full Text] [Related]
35. Molecular characteristics of Chinese patients with Rett syndrome.
Zhang X; Bao X; Zhang J; Zhao Y; Cao G; Pan H; Zhang J; Wei L; Wu X
Eur J Med Genet; 2012 Dec; 55(12):677-81. PubMed ID: 22982301
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial Dysfunction in the Pathogenesis of Rett Syndrome: Implications for Mitochondria-Targeted Therapies.
Shulyakova N; Andreazza AC; Mills LR; Eubanks JH
Front Cell Neurosci; 2017; 11():58. PubMed ID: 28352216
[TBL] [Abstract][Full Text] [Related]
37. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides.
Sztainberg Y; Chen HM; Swann JW; Hao S; Tang B; Wu Z; Tang J; Wan YW; Liu Z; Rigo F; Zoghbi HY
Nature; 2015 Dec; 528(7580):123-6. PubMed ID: 26605526
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of genetic MECP2 supplementation in the R294X mouse model of Rett syndrome.
Collins BE; Merritt JK; Erickson KR; Neul JL
Genes Brain Behav; 2022 Jan; 21(1):e12739. PubMed ID: 33942492
[TBL] [Abstract][Full Text] [Related]
39. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
